Insider Transactions in Q3 2021 at Oric Pharmaceuticals, Inc. (ORIC)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 15
2021
|
Jacob Chacko PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
3,736
-58.48%
|
$93,400
$25.06 P/Share
|
|
Sep 15
2021
|
Richard A. Heyman |
SELL
Open market or private sale
|
Indirect |
682
-0.31%
|
$17,050
$25.03 P/Share
|
|
Sep 14
2021
|
Jacob Chacko PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
4,420
-40.9%
|
$110,500
$25.05 P/Share
|
|
Sep 14
2021
|
Richard A. Heyman |
SELL
Open market or private sale
|
Indirect |
706
-0.32%
|
$17,650
$25.05 P/Share
|
|
Sep 13
2021
|
Jacob Chacko PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
2,801
-20.58%
|
$70,025
$25.02 P/Share
|
|
Sep 13
2021
|
Richard A. Heyman |
SELL
Open market or private sale
|
Indirect |
601
-0.28%
|
$15,025
$25.01 P/Share
|
|
Sep 10
2021
|
Jacob Chacko PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
2,942
-17.78%
|
$73,550
$25.08 P/Share
|
|
Sep 10
2021
|
Richard A. Heyman |
SELL
Open market or private sale
|
Indirect |
479
-0.22%
|
$11,975
$25.1 P/Share
|
|
Sep 08
2021
|
Jacob Chacko PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
200
-1.19%
|
$5,000
$25.04 P/Share
|
|
Sep 07
2021
|
Jacob Chacko PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
5,981
-26.31%
|
$149,525
$25.11 P/Share
|
|
Sep 07
2021
|
Richard A. Heyman |
SELL
Open market or private sale
|
Indirect |
1,086
-0.49%
|
$27,150
$25.11 P/Share
|